Kenkone Medical Co., Ltd

Kenkone is committed to using AI-driven solutions to ensure the comprehensive documentation of medical processes, alleviating the burden on healthcare professionals while maximizing the quality of care provided to patients. Our flagship product, EVAS, harnesses generative AI and speech recognition technology to assist healthcare professionals in timely documentation and generation of medical records during surgeries, significantly reducing their burden of medical record writing and ensuring complete documentation of patient conditions. EVAS has been successfully implemented in numerous hospitals and clinics in Taiwan, validating its market adaptability and business model. Recently, we have also established partnerships with other hospitals in Japan, including the National Cancer Center Japan, Tokyo University Hospital, Keio University Hospital, marking a significant milestone in our expansion efforts. This groundbreaking product has garnered high praise from the president of the World Endoscopy Organization. Recently selected by NVIDIA Inception Taiwan, EVAS has been recognized as a highly promising medical AI application. It has secured investments from several hospitals in Taiwan as well as companies in Japan.

https://www.kenkone.com/en/home-en/

WADE LIAO
CEO

Nominated by

President participating in the establishment of CDIB Capital Innovation Accelerator,
Innovation Fund I and CDIB Cross Border Innovation Fund II.
CDIB Capital Group recommends Kenkone Medical to participate in this competition due to its strong track record in innovative healthcare solutions and successful market penetration in both Taiwan and Japan. Kenkone’s flagship product, EVAS, has already been implemented in top-tier hospitals, demonstrating its effectiveness in improving medical record accuracy and reducing the workload of healthcare professionals. As a pioneer in AI-driven medical technologies, Kenkone is well-positioned to showcase its cutting-edge solutions on a global stage. This competition offers an excellent platform for Kenkone to expand its presence in the Japanese market, attract strategic partnerships, and further solidify its role as a leader in healthcare innovation.